Asio Capital’s Gilead Sciences GILD Stock Holding History

Asio Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-135	Closed	-$10K	–	99
2020 Q2	$10K	Buy	+135	New	+$10.3K	0.01%	133

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Asio Capital's GILD Position: Q3 2020 in Review

Asio Capital sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 135 shares — an estimated $10K sold.

Asio Capital first reported a position in GILD in Q2 2020 and held it in 1 quarter. The position peaked at $10K in Q2 2020. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

Asio Capital reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
Asio Capital sold 135 Gilead Sciences shares in Q3 2020, an estimated $10K.
Asio Capital first reported a position in Gilead Sciences in Q2 2020 and held it in 1 quarter.
Asio Capital's Gilead Sciences position peaked at $10K in Q2 2020.
1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Asio Capital's 13F filing for Q3 2020, filed 15 Oct 2020.